Where the exam and the imaging leave function undocumented, WAVi records quantified EEG and event-related potentials in about twenty minutes and TM-Flow records autonomic and vascular measures in about ten, ordered when clinically indicated.
Because the exam and the imaging often leave function undocumented. WAVi quantifies resting EEG rhythms and P300 amplitude, latency, and reaction time against an age-matched normative database, and TM-Flow records autonomic and sudomotor indices. Both are aids to diagnosis captured on a repeatable protocol, so a retest is a genuine comparison. You interpret; the device measures.
WAVi records resting EEG awake and drowsy plus event-related potentials including P300, in about twenty minutes on a gel-free saline headset. TM-Flow adds heart rate variability and sudomotor response chairside in about ten minutes.
Data captures in your office; interpretation comes back from BMTG board-certified neurologists through a HIPAA-compliant portal. Your practice does not need to add an in-house EEG reader to run the program.
Repeat both scans the same way after a course of care, so measured change sits next to the exam. Retest frequency is decided by your payer on documented medical necessity, never on a fixed schedule.
WAVi is FDA 510(k) cleared (K213900), an EEG and event-related potential system cleared to aid in diagnosis, not to diagnose any condition on its own. TM-Flow is built on three FDA 510(k)-cleared modules (K173696, K152216, K200141) for autonomic, sudomotor, and vascular indices. ALTMS is FDA-cleared rTMS (K220625) for adults with major depressive disorder who have not improved on prior antidepressant medication. Provider-ordered genetic panels run through PreCheckHealth.
Quantified EEG and event-related potentials to aid cognitive workups and track change from baseline to retest. Retest frequency is decided by your payer on documented medical necessity. Wellness programs: before and after treatment, typically 4 to 6 weeks or 12 weeks.
Autonomic function, sudomotor, and ankle-brachial testing in one visit, measuring HRV, sudomotor response, and ABI for the chart. TM-Flow System, built on three FDA 510(k)-cleared modules (K173696, K152216, K200141).
Provider-ordered panels through PreCheckHealth: the Comprehensive Neurogenetic Panel (203 genes) when the presentation or the family history raises an inherited question, and PharmacoCheck+ for drug-metabolizing enzyme variants before a prescribing decision. Run by a CLIA-certified lab. Clinical, not a consumer test.
ALTMS is our FDA-cleared rTMS line for adults with major depressive disorder who have not improved on prior antidepressant medication. The Hue Light BAHI suite adds a cash-pay recovery layer, positioned under general wellness.
FDA-cleared rTMS therapy for adults with major depressive disorder who have not improved on prior antidepressant medication. Billable through a full course of treatment when the payer's TMS coverage criteria are met.
Photobiomodulation, molecular hydrogen, pressurized oxygen, and whole-body vibration. A recovery and longevity layer alongside the care plan.
BMTG is TITN's interpretation arm. You order the test; a board-certified neurologist reads it and the report comes back to you. The Cognitive Function Report is your clinical track. The Post-Injury Brain Function Report covers the cases that become legal matters, with you as the ordering provider throughout.
Read by a BMTG board-certified neurologist, or by your own neurologist using our templates, returned through our HIPAA portal inside 7 business days.
When a patient's injury becomes a personal-injury matter, the same WAVi data supports a neurologist-signed report of measured findings written for the record. You stay the ordering provider; billed to the patient or on a lien depending on case structure.
TITN and BMTG reach attorneys through education only. The ordering provider is the customer. The report does not diagnose; it documents measured data a clinician interprets, and admissibility is determined by the court.
The reason clinics keep the equipment running is the wrap around it. Here is what comes with a neurology placement, and how we build the practice around it.
Live sessions, recorded walkthroughs, and interpretation guides. Your team runs real tests; a TITN clinical trainer reviews the reports with them until interpretation sticks.
The coverage checklist per device, your contractor's policy read with you, documentation templates, and your certified coder in the loop.
On-site or remote setup, calibration, and staff onboarding. A named TITN contact, not a ticket queue.
Flexible financing structures built around your expected reimbursement timeline. Multiple lender and lease pathways with transparent ROI modeling.
Workflow design, reimbursement coaching, protocol setup. Practical, billable advice.
Mobile-first WordPress sites with scheduling baked in. The same aesthetic as this one.
AI-generated brand films or full productions filmed at your clinic. Edited, scored, finished.
Local SEO, structured data, and CRM lead-intake that routes new-patient inquiries automatically.
The questions a neurology practice asks before it orders anything.
WAVi for a quantified EEG and event-related-potential baseline, and TM-Flow for autonomic, sudomotor, and vascular indices. WAVi is FDA 510(k) cleared (K213900) to aid in diagnosis, not to diagnose any condition on its own, and runs in about twenty minutes; TM-Flow is built on three FDA 510(k)-cleared modules and runs chairside in about ten minutes. Both are ordered when clinically indicated, and a board-certified neurologist's read comes back through BMTG. Provider-ordered genetic panels, the Comprehensive Neurogenetic Panel and PharmacoCheck+, run through PreCheckHealth.
Coverage is decided by your payer on the documented indication. WAVi is billed under the standard codes for the services performed, with the physician's cognitive assessment visit billed separately when it is performed. TITN recommends no code for TM-Flow; each Medicare contractor and plan decides, and California's contractor publishes no autonomic policy. Ask us for the coverage checklist and confirm every code with your certified coder.
K213900 clears the WAVi SCAN software for the acquisition, display, and storage of a patient's brain electrical activity, including EEG and event-related potentials, to aid in diagnosis. That is the whole claim. It is not a clearance to detect, diagnose, or rule out any condition, and it says nothing about TM-Flow, which carries three module-level clearances rather than a device-level one.
No. Published work shows P300 changes correlate with mild cognitive impairment and Alzheimer's disease, and performs best when combined with other biomarkers, but current guideline consensus does not support it as a standalone diagnostic. The BMTG Cognitive Function Report documents measured WAVi and autonomic data for the ordering clinician to interpret; it does not diagnose mild cognitive impairment or any other condition.
Admissibility is decided by the court and varies by jurisdiction. Several state courts have excluded qEEG offered to diagnose traumatic brain injury, so no report should ever be presented as court-proof or as standalone proof of injury. The BMTG Post-Injury Brain Function Report presents instrument-recorded EEG and ERP measurements interpreted by a board-certified neurologist who can support deposition; it does not assign legal causation or liability.
Autonomic testing, including sudomotor and cardiovagal measures, is a recognized adjunct in the small fiber neuropathy workup alongside clinical exam and skin biopsy for intraepidermal nerve fiber density. TM-Flow records sudomotor response from galvanic skin response and autonomic function from heart rate variability as measured indices. It supports the workup; it does not replace biopsy-based confirmation, and a normal result does not exclude the diagnosis.
You need a trained technician to run the headset, not an in-house EEG reader. WAVi captures data in your office on a rapid-placement, gel-free saline headset, and the interpretation comes back from BMTG's board-certified neurologists through TITN's HIPAA-compliant portal, with a board-certified neurologist signing the conclusion. TITN provides the training on placement, software, and protocol consistency.
They are separate deliverables for separate uses. The Cognitive Function Report is the clinical track: WAVi brain data plus TM-Flow autonomic data combined into one neurologist-interpreted cognitive assessment for the ordering provider, standard turnaround inside 7 business days. The Post-Injury Brain Function Report is the med-legal track for personal-injury cases: WAVi only, signed by a board-certified neurologist, available standalone without a device purchase. Do not conflate the two in intake.
Two of them do. The Comprehensive Neurogenetic Panel covers 203 genes and is ordered when the presentation or the family history raises an inherited question. PharmacoCheck+ reports variants in five drug-metabolizing enzymes as one input the prescriber weighs against published gene-drug guidance. Both are provider-ordered, run on a buccal swab by a CLIA-certified lab, and billed by PreCheckHealth, not by your practice. The panel reports variants; interpretation stays with the ordering clinician, and genetic counseling is available through the lab.
A short call covers devices, reimbursement, and onboarding for your workflow. No commitment beyond the first conversation.
Roberto or Weston takes the call personally. We walk you through WAVi, TM-Flow, the report layer, and the billing path for neurology.
Pick a time →A de-identified, watermarked sample of the neurologist-read cognitive report your practice would receive.
Open the sample →FDA 510(k) clearances verified in the openFDA device database. Coverage policies are read in the CMS Medicare Coverage Database. Coverage and payment are decided by each payer on the documented indication; nothing on this site is a guarantee of payment.